Atlas Trials

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Clinical trial NCT03339297 · COMPLETED

Trial details

NCT number
NCT03339297
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft-versus-host DiseaseAcute-graft-versus-host Disease
Start date
2018-02-21
Primary completion
2020-05-12
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.